Platelet/Leukocyte activation, inflammation, and uremia

Related Experiment Video

Updated: Jun 20, 2026

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
08:50

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets

Published on: April 9, 2018

Griet Glorieux1, Gerald Cohen, Joachim Jankowski

  • 1Department of Internal Medicine, Renal Division, Ghent University Hospital, Gent, Belgium. griet.glorieux@ugent.be

Seminars in Dialysis
|August 28, 2009
PubMed

Insights

Chronic kidney disease (CKD) involves inflammation that worsens atherosclerosis. Uremic toxins, particularly middle molecules, activate platelets and leukocytes, driving disease progression.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Immunology

Background:

  • Chronic kidney disease (CKD) is characterized by chronic inflammation.
  • This inflammation accelerates inflammatory conditions like atherosclerosis.
  • Platelet and leukocyte activation in uremia are key contributors.

Purpose of the Study:

  • To discuss the effects of uremic retention solutes on platelet and leukocyte functions.
  • To summarize the role of specific uremic toxins in disease progression.
  • To identify potential therapeutic targets for CKD-related inflammation.

Main Methods:

  • Review and summarization of existing literature on uremic toxins.
  • Analysis of the impact of specific solutes on cellular functions.
  • Discussion of pathophysiological pathways involved in CKD inflammation.

Main Results:

  • Uremic conditions activate platelets and leukocytes.
  • Middle molecules (MW > 500 Da) and protein-bound solutes are major uremic toxins.
  • These toxins significantly affect platelet and leukocyte functions.

Conclusions:

  • Understanding uremic toxins is crucial for managing CKD.
  • Targeting specific toxins may offer new therapeutic strategies.
  • Pharmacological neutralization or removal of toxins could mitigate atherosclerosis progression.

More Related Videos

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls10:16

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls

Published on: January 4, 2018

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...